AbbVie Inc. (ABBV)
Symbol Info
Listed Symbol ABBV
Name AbbVie Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $3,59
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $32.753.000.000
Latest Fiscal EPS $3.68
Price Info
21 Day Moving Average $72,0341
21 Day EMA $71,700380
50 Day Moving Average $68,0449
50 Day EMA $70,066260
200 Day EMA $73,789590
200 Day Moving Average 74,059250
52 Week High $94.98
52 Week Low $62,66
52 Week Change $-13.315301
Alpha 0.001964
Beta 0.9702
Standard Deviation 0.078049
R2 0.182415
Periods 60
Share Information
10 Day Average Volume 7.340.546
20 Day Average Volume 7.687.163
30 Day Average Volume 7.977.065
50 Day Average Volume 8.201.246
Outstanding Shares 1.478.483.838
Float Shares 1.476.820.991
Percent Float 99,89%
Short Interest 54.264.225
Short Percent Float 3,70%
Short Interest Ratio 6,57
Short Date 2019-09-13
Holders
Institutions 3.238
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 83.067.080
Institute Holdings Percent -
Institute Sold Previous 3 Months 174.059.168
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 13
Insider Holdings Percent 0,10%
Insider Sold Previous 3 Months -
Insiders Shares Owned 1.662.847
Price Change
7 Day Price Change $0,0430145
7 Day Percent Change 0,06%
21 Day Price Change $2,2803879
21 Day Percent Change 3,20%
30 Day Price Change $5,1387100
30 Day Percent Change 7,50%
Month To Date Price Change $-1,0018
Month To Date Percent -1,34%
90 Day Price Change $4,468506
90 Day Percent Change 6,46%
Quarter To Date $-1,001755
Quarter To Date Percent -1,34%
180 Day Price Change $-4,71553
180 Day Percent Change -6,02%
200 Day Price Change $-2,550179
200 Day Percent Change -3,35%
Year To Date $-13,628944
Year To Date Percent -15,62%
Profile
Description AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.
Details
Issue Type CS
Market Cap $108.860.764.992
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 1.478.483.838
CEO Richard A. Gonzalez
Employees 30.000
Last Audit UE
Classification
CIK 0001551152
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 1 North Waukegan Road
North Chicago, IL 60064-6400
Website http://www.abbvieinvestor.com
Facisimile
Telephone +1 847 932-7900
Email
Key Ratios
Profitability
EBIT Margin 15,90
EBITDA Margin 21,7
Pre-Tax Profit Margin 23,0
Profit Margin Cont 5,62
Gross Margin 77,40
Profit Margin TOT 5,62
Income Statements
Revenue $24.388.000.000
Revenue Per Share $16,4953
Revenue 3 Years $3,57
Revenue 5 Years $8,37
Valuation Measures
PE Ratio 25,60
Enterprise Value $112.175.796.213
Price To Sales 4,463702
Price To Free Cash 32,700000
PE High Last 5 Years 65,1
Price To Book 39,3
Price To Cash Flow 8,0
PE Low Last 5 Years 16,3
Price To Tangible Book -2,4
Financial Strength
Total Debt To Equity -
Int Coverage 3,6
Current Ratio 0,9
Leverage Ratio -4,9
Quick Ratio 0,6
Long Term Debt To Capital -
Assets
Receivables Turnover 1,7
Invoice Turnover 4,00
Assets Turnover 0,20
Management Effectiveness
Return Assets 6,89
Return On Equity -68,55
Return On Capital -
Dividends
Dividend 3 Years $19,82
Dividend 5 Years $18,08
Ex Dividend Date 2019-10-11 00:00:00.0
Dividend Rate $4,28
Dividend Yield 5,81%
Payment Type Cash
Kürzlich von Ihnen besucht
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
P: V:de D:20191018 02:26:27